Federal Circuit Upholds Arthrex’s Victory in Medical Device Patent Dispute

In a notable decision for the medical device industry, the Federal Circuit has once again sided with Arthrex Inc., affirming the Patent Trial and Appeal Board’s (PTAB) previous rulings. The PTAB had previously invalidated several claims within a group of medical device patents challenged by Arthrex. This affirmation, delivered without any accompanying explanation, solidifies Arthrex’s position in this ongoing intellectual property dispute. For further details on this decision, the original article is available on Law360.